Protocol SAKK 77/06 and SASL 23 Continuous sunitinib treatment in patients with unresectable hepatocellular carcinoma A multicenter phase II trial

Update Il y a 4 ans
Reference: EUCTR2007-003977-22

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To demonstrate antitumor activity of continuous sunitinib (Sutent®) treatment in patients with unresectable hepatocellular carcinoma.


Inclusion criteria

  • Patients with unresectable hepatocellular carcinoma, localized but surgically unresectable or metastatic

Links